PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026eJHaem0 citationsOpen Access

Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease

View Full Paper
JGJahnavi GollamudiCWChengzhou WuGKGuolian Kang

Key Points

  • This study aims to quantify the prevalence of low bone mineral density across different age groups in individuals with sickle cell disease.
  • Retrospective data analysis from the Sickle Cell Clinical Research and Intervention Program with 713 participants, ages 6–24.
  • Calculated age-, sex-, ancestry-, and height-adjusted Z-scores for lumbar spine and total body bone mineral density using healthy African American controls.
  • Performed multivariable analysis to identify predictors for low total body bone mineral density.
  • Prevalence of low total body bone density increased with age: 29.5% (children), 36.7% (adolescents), and 42.2% (young adults).
  • Older age (OR 1.10, 95% CI 1.06–1.16), lower hemoglobin (OR 0.833, 95% CI 0.740–0.936), and higher eGFR (OR 1.01, 95% CI 1.00–1.02) independently predicted low total body bone mineral density.

Abstract

ABSTRACT Introduction Skeletal complications are common in sickle cell disease (SCD). We previously showed that the prevalence of low areal bone mineral density (aBMD) increased with age in a pediatric SCD cohort, even after adjusting for short stature. Data on age‐related aBMD trends in young adults is lacking. Methods Using retrospective data from the Sickle Cell Clinical Research and Intervention Program (SCCRIP), we converted lumbar spine (LS) and total body (TB) aBMD from 713 SCCRIP participants (49.2% females, ages 6–24 years) to age‐, sex‐, ancestry‐, and height‐adjusted Z ‐scores, using data from healthy African American controls enrolled in the Bone Mineral Density in Childhood Study. Results Low TB bone density prevalence rates increased with age: 29.5% in children (6–< 12 years), 36.7% in adolescents (12–< 18 years), and 42.2% in young adults (18–24 years). LS aBMD followed a similar age‐related trend. Multivariable analysis revealed older age (OR 1.10, 95% CI 1.06–1.16), lower hemoglobin (OR 0.833, 95% CI 0.740–0.936), and higher eGFR (OR 1.01, 95% CI 1.00–1.02) as independent predictors for low TB BMD. Conclusion These findings highlight the progressive decline of aBMD in SCD and underscore the need for early screening to mitigate morbidity due to SCD‐related skeletal complications. Trial Registration : The authors have confirmed clinical trial registration is not needed for this submission

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gollamudi et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5122f03e14405aa9d802https://doi.org/10.1002/jha2.70306
Ask AI
Helpful
Bookmark
Share
View Full Paper